Division of Hematology/Oncology

Head and Neck Cancer Program

Penn Medicine head and neck cancer clinicians and researchers are leading the way nationally in the diagnosis and treatment of head and neck cancers.

Penn physicians have been leaders in the development of molecular targeted therapies such as cetuximab for the treatment of head and neck squamous cell cancer. In addition, Penn researchers have been leaders in the development of molecularly targeted therapies such as sorafenib for the treatment of advanced thyroid cancer.

Penn hematologists/oncologists work closely with Penn head and neck surgeons. Penn head and neck surgeons developed transoral robotic surgery (TORS) and established the world's first program in the innovative technique. TORS is a minimally invasive, robotic-assisted surgical approach for the removal of tumors of the mouth, throat and voice box. Using this approach, tumors can often be removed completely while preserving speech, swallowing, and other key functions, thus maintaining patient quality of life.

A Multidisciplinary Approach to Care

Cancer specialists within the Center for Head and Neck Cancer are full-time Penn faculty, who have dedicated their clinical and research careers to improving our ability to diagnose and treat head and neck cancers.

Penn hematologists/oncologists are part of a multidisciplinary team of specialists, including endocrinologists, radiation and surgical oncologists, dentists and maxillofacial physicians, and integrative medicine specialists. Their collective goal is to treat the entire person — not just the disease.

Services in the Center for Head and Neck Cancer

Services offered at the Center for Head and Neck Cancer include:

  • Chemotherapy
  • Dentistry
  • Diagnosis
  • Endocrinology
  • Nutrition
  • Pathology
  • Physical therapy
  • Radiation therapy
  • Reconstructive surgery
  • Speech therapy
  • Surgery

The Penn Difference

  • Penn was one of the first centers nationally to establish a multidisciplinary center for the treatment of head and neck cancer.
  • Penn surgeons invented TORS and established the world's first TORS program. TORS is a minimally invasive, robotic-assisted surgical approach to removing tumors of the mouth, throat and voice box. Using this approach, tumors can often be completely removed while preserving speech, swallowing, and other key functions, thus maintaining quality of life.
  • Specialists at the Center for Head and Neck Cancer offer state-of-the-art surgical and non-surgical approaches to treat advanced head and neck cancer with surgery, radiation and chemotherapy to allow preservation of normal structures and function while controlling the cancer.
  • Penn's Center for Head and Neck Cancer is one of the largest thyroid cancer programs on the East Coast.

Center for Head and Neck Cancer Team

Hematologists/oncologists within the Center for Head and Neck Cancer include:

Loading Provider List...

Learn more about the Center for Head and Neck Cancer